Spinal Cord Injury (SCI) Clinical Trial
Official title:
A Phase 1, Open-label, Single-site, Safety Study of Human Spinal Cord-derived Neural Stem Cell Transplantation for the Treatment of Chronic SCI
This is a safety study of human spinal cord-derived neural stem cell (HSSC) transplantation for the treatment of chronic spinal cord injury.
Phase I, open-label, single-site, safety study of HSSC transplantation for the treatment of chronic spinal cord injury (SCI). Group A enrolled 4 subjects with a cord injury at T2-T12; Group B will enroll 4 subjects with a C5-C7 cord injury. Study period will be 6 months post-operative. Post-study, subjects will be followed for an additional 54 months. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04295538 -
Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI)
|
Phase 2 | |
| Completed |
NCT01232907 -
The Effects of L-carnitine on Fatigue in Spinal Cord Injury
|
Phase 2 | |
| Not yet recruiting |
NCT01771159 -
Tissue Bonding Cystostomy(TBC)
|
Phase 1 | |
| Completed |
NCT02052024 -
Myobloc Atrophy Study
|
Phase 4 | |
| Completed |
NCT02469675 -
Brain and Nerve Stimulation for Hand Muscles in Spinal Cord Injury and ALS
|
N/A | |
| Completed |
NCT00488280 -
Restoring Walking in Non-ambulatory Children With Severe Chronic Spinal Cord Injury (SCI) (Kids STEP Study)
|
Phase 1 | |
| Completed |
NCT03833674 -
FLO2 for Recovery After SCI
|
N/A |